Leucine-rich amelogenin peptide induces osteogenesis by activation of the Wnt pathway
Authors:
- 1 September 2009
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 387 (3) , 558-563
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR047052)
- National Institute of Dental and Craniofacial Research (DE017362, DE13045)
- University of Southern California
This publication has 29 references indexed in Scilit:
- A Gata6-Wnt pathway required for epithelial stem cell development and airway regenerationNature Genetics, 2008
- Identification of the functional activity of the [A-4] amelogenin gene splice product in newborn mouse ameloblastsBone, 2008
- Leucine-rich amelogenin peptide induces osteogenesis in mouse embryonic stem cellsBiochemical and Biophysical Research Communications, 2008
- The Role of Enamel Matrix Proteins in the Development of Cementum and Periodontal Tissues2007
- Characterization of a mouse amelogenin [A−4]/M59 cell surface receptorBone, 2006
- Secreted WNT antagonists as tumor suppressors: pro and conFrontiers in Bioscience-Landmark, 2006
- THE WNT SIGNALING PATHWAY IN DEVELOPMENT AND DISEASEAnnual Review of Cell and Developmental Biology, 2004
- Wnt-3a and Dvl Induce Neurite Retraction by Activating Rho-Associated KinaseMolecular and Cellular Biology, 2004
- Characterization of a Procine Amelogenin Preparation, EMADOGAIN, a Biological Treatment for Periodontal DiseaseConnective Tissue Research, 2002
- Alternative Splicing of AmelogeninsConnective Tissue Research, 1995